Member Info for Porky9

@Mactrader
I actually 100% agree
They have the capability to knock out an Antibody LFT simply to license elsewhere but for whatever reason are not doing so.. yet. Unless of course something else is in the mix
Time will tell

@Mactrader
Lmol, Don’t be so soft, I appreciate it might not seem like I have any other interests than Novacyt due to focus posting here but I hold 9 stocks - hence why I originally selected the handle Porky 9
I am only adding here I can tell you until £54 lol, but I still check on numerous other stocks and their boards and will occassionally post
Take care

Specifically, for @Airlineboy
I can already feel your Positivity levels increasing.
You will soon be feeling like Captain Positive of the Good Ship Positive, Sailing into incredibly positive waters, with a crew of positive people (any negatives will be thrown overboard) and sailing to Positive Land.
This is how positive you will feel today.
You will also feel mighty handsome and powerful at the same time :)
Hope this helps.
Take care now.
Pork’s

Taken from the previous R & D update:-

"The Company expects to launch its LFT in Q2 2021, slightly later than planned as it has taken the strategic decision to develop a next generation of LFT to detect the neutralizing antibodies generated by successful immunisation and, therefore, to assist in monitoring the effectiveness of future vaccines3. The Company believes this exemplifies how it can extend the revenue horizon for COVID-19 as the demand for testing continues to evolve"

What is interesting about this is that we are now seeing clear worldwide demand starting for Antibody tests especially with the vaccine roll out. FDA have today awarded another US test clearance as an Antibody Home test However, this isn't an instant test, you still need to return it back to the lab:-
https://www.fiercebiotech.com/medtech/symbiotica-s-self-collected-covid-19-antibody-test-becomes-first-to-receive-fda-emergency

So the big question is how next gen is next gen? What will the Novacyt test deliver because IF it can actually tell you percentages of Antibody protection you have rather than just "do i have Antibodies" YES or NO frankly this could be more significant than we think.

Looking forward to further details on this which will be anytime soon. Yet again Novacyt remaining ahead of the curve.

GLA

Porks

Don't forget this is also a key tender we are likely involved in, closes today.
This is the tender we need to pay close attention to
https://bidstats.uk/tenders/2021/W10/746389838
Consumables Reagents and Equipment DPS
Value 4Bn
Duration 4Yrs
Closing Date 08 Apr 2021
Type: Dynamic Purchasing System

A slice of a contract like this would immediately give us the SP longevity boost we need, the more deals they can secure that are on two year or more contracts the better.

With so much going on and the financials established, its amazing the SP isn't at least twice the current level but we are where we are. It will start moving soon as further details are released.

GLA

Thx gkb47, upomega and all - Got it
Will digest that information @takingit easy.
Appreciate the research pieces guys.
TBH i thought the DHSC contract was Antigen. Looks to me that what ODX need is a better quality partner. Clearly they are gearing up for volume production.
GLA

I will check back later, if anyone knows?
But if i were ODX, i guess they are likely already doing this, putting pressure on Mologic to finalise terms i would be saying, get it sorted otherwise i will take my £ 373 m contract elsewhere. The award was given to ODX at the end of the day.
Crazy world

@upomega
As a manufacturer i guess in theory they can manufacture ANY other medical device for that matter not just LFT. As long as they can create a decent margin it doesn't matter.
Has manufacture actually started now in Scotland or do they still need to iron out the Mologic deal?
Cheers

@Penance,
I seek out value opportunities. I have 9 open stock positions in my portfolio. I won't mention them all here. I have ZERO intention what so ever of selling any NCYT stock as my research is substantial and I'm VERY confident but that doesn't stop me switching something else or adding a new position if i deem it viable.
I have traded ODX twice so far. I have a small holding sub £10k but before the DHSC win i considered them a total waste of time, now they have that order its at least worth me investigating this a bit further?
If you have the knowledge and can share great, if not i will continue on my own as time affords. I have been to a family funeral today (covid) and in the bigger life picture it really doesn't matter.
Take Care now
Pork's.

@Trickymatters
The Wembley deal will give data from 4,000 . They will LFT test all on the way in and PCR after the game. What it will do is deliver some really good empirical data on accuracy in its use at Big game events. IF the data goes the way you want potentially it can open up big venue events in the UK and create more business opportunities.
It is a positive.

Hi,
This is a genuine question i would like to ask those really following this company closely please
It's out of hours so please don't kick off as i have historically been skeptical about ODX chances of success. Am i understanding this correctly:-

They won a MAJOR contract from DHSC for up to £ 373m which is a game changer for them. To be fare this is a really good win and the hard bit. Not many businesses can claim an order that size. Then same day put out an RNS saying effectively they could only start it once they had a product they could manufacture. Then along come Mologic and then ODX say we have a CE mark of the Mologic LFT and can start manufacturing this product from this month. Great

So Does this mean that IF say another tech coy, a competitor of Mologic came up with a better LFT or even a similar one BUT agreed a lower royalty per test hence, increasing ODX margin per unit they could switch??? OR does anyone know if the Mologic deal is binding and prevents them securing a better deal elsewhere?

From my own perspective i'm still struggling to put a realistic fundamental valuation together here you see, i'm not sure how much cut Mologic take in royalties per unit, there was a rumor it was £1 a unit? how negotiable this is and as i say if they can switch if a better deals comes available.

Can anyone provide clarity? Thanks in advance

Pork's

Singapore has decided to accept the pre-departure Covid-19 PCR test results on the IATA Travel Pass from next month.
This move comes after Singapore Airlines successfully implemented the International Air Transport Association (IATA) Travel Pass mobile application pilot on its flight to London, UK, last month.
Starting 1 May, passengers travelling to Singapore can share pre-departure Covid-19 PCR test results through IATA Travel Pass during check-in, and on arrival at the immigration checkpoints at Changi Airport.
https://www.aerospace-technology.com/news/singapore-iata-travel-pass-covid-19/

NOTE:
"Besides Singapore Airlines, more than 20 airlines have announced trials of the IATA Travel Pass"

So whilst it might be kicking off in Westminster a Covid Passport is in breach of human rights etc ROW are clearly running with it alongside negative PCR test.

Interesting..

Well if they are going to make a series of acquisitions then it makes perfect sense to have your own legal team inhouse ready to prepare the deals good to go.

I'm still on the page that cignpost for mobile labs and its proximity to Novacyt HQ was a good match to extend the mobile lab facilities and likewise Biograd for its similar growth in static labs. A network of that nature could be used for local and regional diagnostics in numerous areas. Time will tell.

Clearly they want to move into non covid areas, but also we still need something in Informatics imo. Any acquisition play in something informatics related would be absolutely superb if they want to become that all rounded diagnostics group. This is what i would like to see.

Very lucky young man indeed to have a spare £40k around at 18 to put in his first ISA
Equally lucky that his uncle has given him good advice to invest it in a stock with great fundamental value and not one-off those hyped up stocks you see around :)

Zero panic - We are the only ones making any revenue, 270m EBITDA and between 130 and 140m cash at bank!
No concerns there

In that case it’s a positive as the full year absolutely blows H1 away, the details due in a couple of weeks or so. I would take PE x14 on current earnings all day long!!!
SP would sky rocket
Very Very confident
GLA

Currently with our market cap this low its just totally defies all logic

£ 213m revenue in H2 2020 and on course to exceed in H1 2021. Cash at bank for acquisitions must be in the region of £130m to £ 140m and all this is without anything else and we still don't know what all those NHS related appointments are for. mcap at close today £ 485m you couldn't make it up.

They are winning regular orders like that Romania one:-
https://twitter.com/nolfa77/status/1379357628959240192
1.5m and it doesn't warrant a mention and there are numerous other ones like that from governments around the world.

I totally get that we are currently all out of favour and shareholders are chasing other stocks. Also a number have been bored into selling, lol. I also get that the talk is all LFT at the moment but Variants need to be kept in check that's for sure, it only takes one new variant of concern to get into the UK and we are back to square one.

We can only hope that as we are now entering news season that interest starts rebuilding again. Some positive news flow will do us the power of good frankly. At least we know the annual accounts are superb and they are due to be published shortly.

Anyhow, business continues to build which is the main thing, they are massively increasing staff numbers and that's not the signs of a company in decline is it, so i remain confident.

Good luck all

Pork's

Hi Luckyno7
So Thermo Fisher Hospital PCR tests in the USA fail to pick up Variant B.1.1.7 aka the Kent variant, in addition to Applied and Mesa Biotech.
We have got boots on the ground stateside and a number of decent sized distributors out there now so its a matter of time if not already before we secure a decent sized order.

Bodes well for some Major orders Stateside, fantastic.

GLA
https://www.medpagetoday.com/special-reports/exclusives/91941

So Thermo Fisher Hospital PCR tests in the USA fail to pick up Variant B.1.1.7 aka the Kent variant, in addition to Applied and Mesa Biotech.
Good Job #Novacyt can detect ALL Variants
Bodes well for some Major orders Stateside, fantastic.
https://www.medpagetoday.com/special-reports/exclusives/91941

I do agree, France is in an absolute mess, they need Novacyt's help for sure.

They have just gone into another four week lock down
https://www.france24.com/en/france/20210404-france-enters-four-week-covid-19-light-lockdown
Same situation in Germany

Mind you with all the recruitment going on at Novacyt it looks like they need all the help they can get to process what they already have orders for.

I recon its going to be a very interesting week - GLA